Park SY - Search Results

1

Ginsenoside Rc Is a New Selective UGT1A9 Inhibitor in Human Liver Microsomes and Recombinant Human UGT Isoforms.

Lee H, Heo JK, Lee GH, Park SY, Jang SN, Kim HJ, Kwon MJ, Song IS, Liu KH. Lee H, et al. Among authors: park sy. Drug Metab Dispos. 2019 Dec;47(12):1372-1379. doi: 10.1124/dmd.119.087965. Epub 2019 Oct 2. Drug Metab Dispos. 2019. PMID: 31578207

2

In vitro modulatory effects of ginsenoside compound K, 20(S)-protopanaxadiol and 20(S)-protopanaxatriol on uridine 5'-diphospho-glucuronosyltransferase activity and expression.

Jang SN, Park SY, Lee H, Jeong H, Jeon JH, Song IS, Kwon MJ, Liu KH. Jang SN, et al. Among authors: park sy. Xenobiotica. 2021 Oct;51(10):1087-1094. doi: 10.1080/00498254.2021.1963503. Epub 2021 Aug 13. Xenobiotica. 2021. PMID: 34338601

3

Comprehensive Investigation of Stereoselective Food Drug Interaction Potential of Resveratrol on Nine P450 and Six UGT Isoforms in Human Liver Microsomes.

Ji SB, Park SY, Bae S, Seo HJ, Kim SE, Lee GM, Wu Z, Liu KH. Ji SB, et al. Among authors: park sy. Pharmaceutics. 2021 Sep 7;13(9):1419. doi: 10.3390/pharmaceutics13091419. Pharmaceutics. 2021. PMID: 34575495 Free PMC article.

4

Strong and Selective Inhibitory Effects of the Biflavonoid Selamariscina A against CYP2C8 and CYP2C9 Enzyme Activities in Human Liver Microsomes.

Park SY, Nguyen PH, Kim G, Jang SN, Lee GH, Phuc NM, Wu Z, Liu KH. Park SY, et al. Pharmaceutics. 2020 Apr 10;12(4):343. doi: 10.3390/pharmaceutics12040343. Pharmaceutics. 2020. PMID: 32290339 Free PMC article.

5

In Vitro Metabolism Study of Seongsanamide A in Human Liver Microsomes Using Non-Targeted Metabolomics and Feature-Based Molecular Networking.

Wu Z, Kim GJ, Park SY, Shon JC, Liu KH, Choi H. Wu Z, et al. Among authors: park sy. Pharmaceutics. 2021 Jul 7;13(7):1031. doi: 10.3390/pharmaceutics13071031. Pharmaceutics. 2021. PMID: 34371722 Free PMC article.

6

Inhibitory Effects of Schisandra Lignans on Cytochrome P450s and Uridine 5'-Diphospho-Glucuronosyl Transferases in Human Liver Microsomes.

Seo HJ, Ji SB, Kim SE, Lee GM, Park SY, Wu Z, Jang DS, Liu KH. Seo HJ, et al. Among authors: park sy. Pharmaceutics. 2021 Mar 10;13(3):371. doi: 10.3390/pharmaceutics13030371. Pharmaceutics. 2021. PMID: 33802239 Free PMC article.

7

In Vitro Metabolism of Donepezil in Liver Microsomes Using Non-Targeted Metabolomics.

Kim SE, Seo HJ, Jeong Y, Lee GM, Ji SB, Park SY, Wu Z, Lee S, Kim S, Liu KH. Kim SE, et al. Among authors: park sy. Pharmaceutics. 2021 Jun 23;13(7):936. doi: 10.3390/pharmaceutics13070936. Pharmaceutics. 2021. PMID: 34201744 Free PMC article.

8

O-1602 Promotes Hepatic Steatosis through GPR55 and PI3 Kinase/Akt/SREBP-1c Signaling in Mice.

Kang S, Lee AY, Park SY, Liu KH, Im DS. Kang S, et al. Among authors: park sy. Int J Mol Sci. 2021 Mar 17;22(6):3091. doi: 10.3390/ijms22063091. Int J Mol Sci. 2021. PMID: 33803038 Free PMC article.

9

Clusterin deficiency induces lipid accumulation and tissue damage in kidney.

Heo JY, Kim JE, Dan Y, Kim YW, Kim JY, Cho KH, Bae YK, Im SS, Liu KH, Song IH, Kim JR, Lee IK, Park SY. Heo JY, et al. Among authors: park sy. J Endocrinol. 2018 May;237(2):175-191. doi: 10.1530/JOE-17-0453. Epub 2018 Mar 21. J Endocrinol. 2018. PMID: 29563234

10

Inhibition of Pyruvate Dehydrogenase Kinase 2 Protects Against Hepatic Steatosis Through Modulation of Tricarboxylic Acid Cycle Anaplerosis and Ketogenesis.

Go Y, Jeong JY, Jeoung NH, Jeon JH, Park BY, Kang HJ, Ha CM, Choi YK, Lee SJ, Ham HJ, Kim BG, Park KG, Park SY, Lee CH, Choi CS, Park TS, Lee WN, Harris RA, Lee IK. Go Y, et al. Among authors: park ts, park kg, park by, park sy. Diabetes. 2016 Oct;65(10):2876-87. doi: 10.2337/db16-0223. Epub 2016 Jul 6. Diabetes. 2016. PMID: 27385159

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,706 results

Search Page